SURREAL. Ecstatic to have matched to my #1 choice. Iโm going to be a cardiologist ๐ซ beyond thankful for my incredible mentors along the way #match2025#cardiology
๐จ ๐๐ฅ๐๐๐๐๐ก๐ from #ACC2026: Two major RCTs just challenged everything we thought about Impella pumps in cardiac care.
The results? Surprising.
The implications? Massive.
A thread on what every cardiologist needs to know ๐งต๐
Can we improve #STEMI outcomes by changing when we intervene?
๐ทSTEMI-DTU evaluates LV unloading with Impella before reperfusion.
A physiology-driven shift in STEMI care?
โก๏ธ Key results: There was no difference!
๐ท heart-muscle damage was not significantly different: 30.8% TV-mAFP vs. 31.9% control
๐ฅ 55
๐๐ป21%
Mean age 61y
47 minutes longer for Impella group in time to reperfusion (but no diff in heart muscle damage despite this delay)
@JACCJournals
#ACC26 #LBCT #STEMIDTU
๐ https://t.co/P2rdqyhAlb
Hi Everyone -
๐ฅธHere are all the 27 late breaking clinical trials presented at @ACCinTouch (ACC.26) with session number, day, time, and objective.
๐ฑSee you in NOLA:
๐๐๐
The goal of this document is to review the objective data pertaining to adverse events associated with stress testing in specific patient populations routinely encountered in the stress lab. @laneduvall@ina_lico@HHCardsFellows
Read now๐https://t.co/ENSfO1zOMr
SURREAL. Ecstatic to have matched to my #1 choice. Iโm going to be a cardiologist ๐ซ beyond thankful for my incredible mentors along the way #match2025#cardiology
Happening now! #ICNCCT24 ๐ซ
So excited to share our findings, and grateful for my mentors and this amazing opportunity to present our research at Seville, Spain! @MyASNC@MikhLdeJesus
Itโs always great seeing our wonderful residents representing @UConnIM. CCACC โ24 yesterday was a blast. So much fun seeing everyone! @ACCinTouch@ACCWIC_CT ๐ซ
Takeaways from #ACC2024. Late breaking trials - take home points @ACCinTouch
1. RELIEVE-HF Trial: In patients with HFrEF and HFpEF, Interatrial Shunt did not show any significant difference in the primary effectiveness endpoint, a composite of all-cause mortality, LVAD/heart transplantation, HF hospitalizations, outpatient worsening HF events.